Intrauterine vacuum-induced hemorrhage control device controls bleeding for vaginal and cesarean deliveries
PPH causes 70,000 maternal deaths annually and 12% of U.S. maternal deaths (2017-2019). Obstetric hemorrhage affects physical, reproductive, and mental health.
The application of an intrauterine vacuum-induced hemorrhage control device resulted in rapid and effective bleeding control for both vaginal and cesarean deliveries, as demonstrated by a real-world study's findings published in the journal Obstetrics & Gynecology. The FDA cleared the JADA system in August 2020 for managing abnormal postpartum uterine bleeding.
A team of researchers led by Dr Goffman and colleagues assessed the real-world effectiveness and safety of a U.S. FDA-cleared intrauterine vacuum-induced-hemorrhage control device for managing PPH (postpartum hemorrhage).
This study was conducted at 16 American centres between October 2020 and March 2022. The primary outcome was evaluated based on treatment success, which was defined as controlling bleeding without additional treatment or recurrence. The study also examined other outcomes, such as blood loss, time to device insertion, indwelling time, bleeding recurrence, and time to bleeding control. The study evaluated treatment success and severe maternal morbidity by assessing blood loss before treatment and collected data on serious adverse events and adverse device effects to assess safety. The study summarized all outcomes by mode of delivery and treatment success by bleeding cause.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.